Peer-reviewedCC BYThe Journal of clinical investigation19 Oct 2026

Multimodal assessment of exceptional responders refines subtyping-directed precision treatment in HR+/HER2– breast cancer

Yi Xiao¹
Fan Yang¹
Ying-Jia Qi¹
Li Chen¹
Hang Zhang¹
Si-Wei Zhang¹
Rui Shan¹
Liang Huang¹
Jun-Jie Li¹
Yi-Zhou Jiang¹
Zhi-Ming Shao¹

¹Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

The Psychosocial Burden of the 'Lazarus Effect': A Systematic Review of Survivor Guilt, Identity Shift, and Discontinuation Anxiety in Exceptional Responders to Cancer Immunotherapy.
Johanna Alcívar Ponce, Wilson Alexander Zambrano Vélez, Marianela Silva Sánchez +1
Diseases (Basel, Switzerland)25 Sep 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Precision Cardio-Oncology: A Multimodal Approach to Cancer Therapy-Related Cardiovascular Toxicity Prediction and Assessment
Carl Simela, Ishikaa Mukherjee, Abhinav Kandala +5
Cancers1 Oct 2026Peer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefEurope PMC
Integrating multimodal data for precise subtyping and prognostication in patients with pulmonary mucinous adenocarcinoma
Weiwei Yang, Chen Chen, Lue Li +5
Translational cancer research13 Aug 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Artificial Intelligence, Multi-Omics, and Multimodal Integration in Precision Radiotherapy for Head and Neck Cancer: From Biological Insights to Treatment Decisions
Miao Rao, Yingjian Wang, Minglun Li +1
Biomedicines1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Digital Twins in Oncology: From Multimodal Data Integration to Precision Clinical Practice.
Annamalai Vairavan, Rupsa Bhattacharjee, Bagyam Raghavan
The Indian journal of radiology & imaging3 Sep 2026Peer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC

Cite

BibTeX

@article{xiao2026multimodal,
  title = {{Multimodal assessment of exceptional responders refines subtyping-directed precision treatment in HR+/HER2– breast cancer}},
  author = {Yi Xiao and Fan Yang and Ying-Jia Qi and Li Chen and Hang Zhang and Si-Wei Zhang and Rui Shan and Liang Huang and Jun-Jie Li and Yi-Zhou Jiang and Zhi-Ming Shao},
  journal = {The Journal of clinical investigation},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13668612},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Multimodal assessment of exceptional responders refines subtyping-directed precision treatment in HR+/HER2– breast cancer
AU  - Yi Xiao
AU  - Fan Yang
AU  - Ying-Jia Qi
AU  - Li Chen
AU  - Hang Zhang
AU  - Si-Wei Zhang
AU  - Rui Shan
AU  - Liang Huang
AU  - Jun-Jie Li
AU  - Yi-Zhou Jiang
AU  - Zhi-Ming Shao
PY  - 2026
DA  - 2026/10/19
JO  - The Journal of clinical investigation
UR  - https://europepmc.org/article/PMC/PMC13668612
SN  - 0021-9738
SN  - 1558-8238
ER  -

Related

Cite